Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Niagen Bioscience, Inc. (OCD1.F)

Compare
5.45
+0.30
+(5.83%)
As of 3:51:02 PM GMT+2. Market Open.

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
CHAMPION RIVER VENTURES, LTD. Director and Beneficial Owner of more than 10% of a Class of Security Purchase Sep 6, 2023 --
CHAU HOI SHUEN SOLINA HOLLY Beneficial Owner of more than 10% of a Class of Security Purchase Aug 20, 2024 --
FRIED ROBERT N Chief Executive Officer Purchase May 31, 2023 --
FRIED ROBERT N. Chief Executive Officer Conversion of Exercise of derivative security Apr 9, 2025 1,646,730
GERBER BRIANNA Chief Financial Officer Purchase Dec 1, 2023 28,674
JAKSCH FRANK LOUIS JR Director Conversion of Exercise of derivative security Dec 13, 2024 2,319,230
LI KA SHING Beneficial Owner of more than 10% of a Class of Security Sale Aug 20, 2024 --
LOPEZ CARLOS LUIS General Counsel Purchase Mar 7, 2025 2,251
PAMIR OZAN Chief Financial Officer Purchase Nov 22, 2024 2,907
PATRICK KRISTIN Director Conversion of Exercise of derivative security Aug 23, 2024 0